Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qideng Mingmu Capsule for Diabetic Macular Edema
CTR20191883Phase 2Terminated
- Sponsor
- Chengdu University of Traditional Chinese Medicine
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Qideng Mingmu Capsule in diabetic macular edema (DME), type 2 diabetes mellitus (T2DM), sponsored by Chengdu University of Traditional Chinese Medicine. Started Sep 2019; status: terminated.
02
Drugs
Qideng Mingmu Capsule
03
Conditions
diabetic macular edema (DME)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20191883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191883.